Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/06 → 11/30/08 |
A Double-Blind, Randomized, 6-week, Parallel-Group Clinical Trail to Assess the Safety and Efficacy of Asacol 4.8 g/day (800 mg Mesalamine Tablet) Versus Asacol 2.4 g/day (400 mg Mesalamine Tablet) for the Treatment of Moderately Active Ulcerative Colitis
- De Villiers, Willem (PI)